Please enable Javascript
Dr. John Fruehauf, Evolent
Dr. John Fruehauf, field medical director at Evolent
Articles by Dr. John Fruehauf, Evolent
Advancing Therapies Have Improved the Prognosis of Metastatic Melanoma
Dr. John Fruehauf, Evolent
Melanoma
|
March 13, 2025
Dr. John Fruehauf details how novel therapies have improved the landscape of metastatic melanoma care.
View More
Dr. John Fruehauf on the Best Therapies for Metastatic Melanoma
Dr. John Fruehauf, Evolent
Melanoma
|
December 19, 2024
Dr. John Fruehauf provided an in-depth overview of treatments for metastatic melanoma.
View More
Dr. John Fruehauf on a New Standard of Care for Stage III Melanoma
Dr. John Fruehauf, Evolent
Melanoma
|
November 7, 2024
Dr. John Fruehauf, Evolent, talks about a new standard of care in the treatment of stage III melanoma.
View More